Hermansky-Pudlak syndrome (HPS) is a genetic disorder characterized by defective lysosome-related organelles. Here, we report the identification of two HPS patients with mutations in the beta 3A subunit of the heterotetrameric AP-3 complex. The patients' fibroblasts exhibit drastically reduced levels of AP-3 due to enhanced degradation of mutant beta 3A. The AP-3 deficiency results in increased surface expression of the lysosomal membrane proteins CD63, lamp-1, and lamp-2, but not of nonlysosomal proteins. These differential effects are consistent with the preferential interaction of the AP-3 mu 3A subunit with tyrosine-based signals involved in lysosomal targeting. Our results suggest that AP-3 functions in protein sorting to lysosomes and provide an example of a human disease in which altered trafficking of integral membrane proteins is due to mutations in a component of the sorting machinery.
Pubmed ID: 10024875 RIS Download
Mesh terms: Adaptor Proteins, Vesicular Transport | Albinism, Oculocutaneous | Antigens, CD | Antigens, CD63 | DNA Mutational Analysis | Fibroblasts | Flow Cytometry | Humans | Lysosome-Associated Membrane Glycoproteins | Melanosomes | Membrane Glycoproteins | Membrane Proteins | Microscopy, Fluorescence | Molecular Sequence Data | Monomeric Clathrin Assembly Proteins | Nerve Tissue Proteins | Phosphoproteins | Platelet Membrane Glycoproteins | Protein Processing, Post-Translational | Proteins | RNA, Messenger
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.